183 related articles for article (PubMed ID: 18420432)
1. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
2. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
[TBL] [Abstract][Full Text] [Related]
3. [Practical use of genetic markers other than C282Y in iron overload disorders].
Brissot P
Gastroenterol Clin Biol; 2002 Nov; 26(11):991-3. PubMed ID: 12483130
[No Abstract] [Full Text] [Related]
4. Monitoring of hepcidin levels in a patient with G80S-linked ferroportin disease undergoing iron depletion by phlebotomy.
Wolff F; Bailly B; Gulbis B; Cotton F
Clin Chim Acta; 2014 Mar; 430():20-1. PubMed ID: 24370385
[No Abstract] [Full Text] [Related]
5. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
Saja K; Bignell P; Robson K; Provan D
Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
[No Abstract] [Full Text] [Related]
7. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
[TBL] [Abstract][Full Text] [Related]
11. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.
Njajou OT; Vaessen N; Joosse M; Berghuis B; van Dongen JW; Breuning MH; Snijders PJ; Rutten WP; Sandkuijl LA; Oostra BA; van Duijn CM; Heutink P
Nat Genet; 2001 Jul; 28(3):213-4. PubMed ID: 11431687
[TBL] [Abstract][Full Text] [Related]
12. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
13. Hemochromatosis caused by mutations in the iron-regulatory proteins ferroportin and H ferritin.
Press RD
Mol Diagn; 2001 Dec; 6(4):347. PubMed ID: 11774199
[No Abstract] [Full Text] [Related]
14. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary hemocromatosis].
Franchini M; Veneri D
Recenti Prog Med; 2004 Oct; 95(10):457-62. PubMed ID: 15560291
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
18. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
[TBL] [Abstract][Full Text] [Related]
19. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
[TBL] [Abstract][Full Text] [Related]
20. Hereditary haemochromatosis.
Mohamed M; Phillips J
BMJ; 2016 Jun; 353():i3128. PubMed ID: 27365180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
